Portal de Periódicos da CAPES

PP016—Exposure to antipsychotics with pro-arrhythmic risk: Combining adverse drug reactions with drug utilization data

2013; Elsevier BV; Volume: 35; Issue: 8 Linguagem: Inglês

10.1016/j.clinthera.2013.07.053

1879-114X

Emanuel Raschi, Elisabetta Poluzzi, Brian Godman, Ariola Koci, Iain Bishop, Marija Kalaba, Ott Laius, Ugo Moretti, Catherine Sermet, Miriam Sturkenboom, Fabrizio De Ponti,

Pharmaceutical studies and practices

This pilot study, within the ARITMO project, evaluated the population exposure to antipsychotics (APs: ATC group N05A, excluding lithium) with proarrhythmic risk, by analyzing the FDA Database (FDA_AERS) and European drug utilization data (12 countries).